Site içinde arama yapın | Myliveroom

Sameer Shewale bir ses eklendi Etkinleştirildi
2026-05-04 07:47:54 - Translate -

Anti-Rheumatics Market Size to Reach USD 84.18 Billion by 2033, Driven by Rising Prevalence of Autoimmune Disorders
Market Overview The global Anti-Rheumatics Market is witnessing steady growth, driven by the increasing prevalence of autoimmune diseases such as rheumatoid arthritis and other inflammatory conditions. According to the latest report by Straits Research, the market was valued at USD 66.24 billion in 2024 and is projected to reach USD 84.18 billion by 2033, growing at a CAGR of 2.7% during...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Rohit More bir ses eklendi Networking
2026-06-17 05:31:13 - Translate -

Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory Disorders
According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...

0 Yorumlar 0 hisse senetleri 511 Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2025-11-03 07:03:20 - Translate -

How the Ustekinumab Market Is Redefining Biologic Therapies for Autoimmune Diseases?
Executive Summary Ustekinumab Market Opportunities by Size and Share CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market research report is a verified and consistent source of information that puts forth a telescopic view of the...

0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme

Please log in to like, share and comment!